21.5 C
New York
Saturday, June 3, 2023

Is Trevi Therapeutics Inc. (NASDAQ: TRVI) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Trevi Therapeutics Inc. (TRVI) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.02, or -0.82%, to $2.43. The Trevi Therapeutics Inc. has recorded 224 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Trevi Therapeutics Announces Publication of Positive Data from the CANAL Trial in IPF Chronic Cough in NEJM Evidence.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

Trevi Therapeutics Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $2.45 and fluctuated between $2.5800 as its day high and $2.4000 as its day low. The current market capitalization of Trevi Therapeutics Inc. is $144.13M. A total of 0.7 million shares were traded on the day, compared to an average of 173.03K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, TRVI has seen 3 BUY and 2 SELL insider trades, representing the acquisition of 23,333 and the disposition of 1,732 shares. Over the last 12 months, there were 4 BUYs and 7 SELLs from insiders. Insiders purchased 50,833 shares during that period but sold 986,172.

In the most recent transaction, Delfini Lisa sold 562 shares of TRVI for 2.89 per share on May 11. After the transaction, the Chief Financial Officer now owns 27,918 company shares. In a previous transaction on Apr 11, Delfini Lisa sold 840 shares at 1.84 per share. TRVI shares that Chief Financial Officer owns now total 26,189.

Among the insiders who sold shares, Delfini Lisa disposed of 892 shares on Mar 13 at a per-share price of $1.75. This resulted in the Chief Financial Officer holding 24,737 shares of TRVI after the transaction. In another insider transaction, Delfini Lisa sold 8,474 shares at $2.45 per share on Feb 13. Company shares held by the Chief Financial Officer now total 23,338.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for TRVI in the last 3 months, the mean price target is $7.33 with high estimates of $9.00 and low estimates of $6.00. In terms of 52-week highs and lows, TRVI has a high of $4.68 and a low of $1.43.

As of this writing, TRVI has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.06 per share and a lower estimate of -$0.1. The company reported an EPS of -$0.06 in the last quarter, which was 40.00% higher than expectations of -$0.1.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TRVI’s latest balance sheet shows that the firm has $36.83M in Cash & Short Term Investments as of fiscal 2021. There were $14.63M in debt and $12.72M in liabilities at the time. Its Book Value Per Share was $1.03, while its Total Shareholder’s Equity was $17.07M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TRVI is Buy with a score of 4.80.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles